Skip to main content
Wednesday, 21 October 2026AboutBecome a reporterContact
GARUD Times
Live

Choose your state

See stories from where you live.

EN
Unconfirmed

Bharat Biotech arm Nucelion, VeGen Bio to partner for CAR-T therapy

Nucelion will serve as the technology transfer and clinical as well as commercial stage manufacturing partner for VeGen Bio’s lead candidate, VL-2511, for multiple myeloma

The Hindu · · 1 min read ·

Bharat Biotech arm Nucelion, VeGen Bio to partner for CAR-T therapy
Bharat Biotech arm Nucelion, VeGen Bio to partner for CAR-T therapy (Image: The Hindu)

Nucelion will serve as the technology transfer and clinical as well as commercial stage manufacturing partner for VeGen Bio’s lead candidate, VL-2511, for multiple myeloma

More in Cricket